- Home
- GREE vs SNTI Comparison
GREE vs SNTI Comparison
Compare GREE & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GREE
- SNTI
- Stock Information
- Founded
- GREE 1937
- SNTI 2016
- Country
- GREE United States
- SNTI United States
- Employees
- GREE N/A
- SNTI N/A
- Industry
- GREE Investment Bankers/Brokers/Service
- SNTI Biotechnology: Pharmaceutical Preparations
- Sector
- GREE Finance
- SNTI Health Care
- Exchange
- GREE Nasdaq
- SNTI Nasdaq
- Market Cap
- GREE 23.4M
- SNTI 19.1M
- IPO Year
- GREE N/A
- SNTI N/A
- Fundamental
- Price
- GREE $1.91
- SNTI $4.67
- Analyst Decision
- GREE Strong Buy
- SNTI Strong Buy
- Analyst Count
- GREE 1
- SNTI 1
- Target Price
- GREE $4.00
- SNTI $12.00
- AVG Volume (30 Days)
- GREE 346.5K
- SNTI 115.8K
- Earning Date
- GREE 11-07-2024
- SNTI 11-14-2024
- Dividend Yield
- GREE N/A
- SNTI N/A
- EPS Growth
- GREE N/A
- SNTI N/A
- EPS
- GREE N/A
- SNTI N/A
- Revenue
- GREE $64,382,999.00
- SNTI N/A
- Revenue This Year
- GREE N/A
- SNTI $11.52
- Revenue Next Year
- GREE N/A
- SNTI $78.57
- P/E Ratio
- GREE N/A
- SNTI N/A
- Revenue Growth
- GREE N/A
- SNTI N/A
- 52 Week Low
- GREE $1.51
- SNTI $1.52
- 52 Week High
- GREE $5.45
- SNTI $16.94
- Technical
- Relative Strength Index (RSI)
- GREE 52.21
- SNTI 56.65
- Support Level
- GREE $1.51
- SNTI $3.72
- Resistance Level
- GREE $1.92
- SNTI $4.93
- Average True Range (ATR)
- GREE 0.14
- SNTI 0.46
- MACD
- GREE 0.03
- SNTI 0.01
- Stochastic Oscillator
- GREE 75.49
- SNTI 81.82
About GREE Greenidge Generation Holdings Inc.
Greenidge Generation Holdings Inc owns and operates a vertically integrated cryptocurrency data center and power generation company. The company owns and operates facilities at two locations: the Town of Torrey, New York, and Spartanburg, South Carolina. The cryptocurrency data center operations generate revenue in the form of bitcoin by earning bitcoin as rewards and transaction fees for supporting the bitcoin network with application-specific integrated circuit computers (ASICs or miners) owned or leased by the company.
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.